In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...

Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in ...

Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

Arsenal have a history of recruiting Dutch players, both in the past and in the present. Within the current squad, Jurrien ...

On December 30, 2025, InflaRx reported detailed Phase 3 data analyses for vilobelimab in pyoderma gangrenosum (PG), a rare, difficult-to-treat ulcerative skin disease, following the trial’s early ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

FOR many micro, small and medium-sized enterprises (MSMEs), the biggest challenge today is no longer product quality or consumer demand. It is access.

Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, ...

Singapore has one of the highest life expectancies in the world, yet many individuals spend almost a decade in poor health ...